Connection

Eric Meissner to HIV Infections

This is a "connection" page, showing publications Eric Meissner has written about HIV Infections.
Connection Strength

2.417
  1. IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency Virus. AIDS Res Hum Retroviruses. 2021 03; 37(3):184-188.
    View in: PubMed
    Score: 0.411
  2. Association of Substance Use With Hospitalization and Virologic Suppression in a Southern Academic HIV Clinic. Am J Med Sci. 2018 06; 355(6):553-558.
    View in: PubMed
    Score: 0.341
  3. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era. Curr Opin Gastroenterol. 2017 May; 33(3):120-127.
    View in: PubMed
    Score: 0.321
  4. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int. 2016 12; 36(12):1783-1792.
    View in: PubMed
    Score: 0.304
  5. Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology. 2005 Jun 05; 336(2):184-97.
    View in: PubMed
    Score: 0.141
  6. Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology. 2004 Oct 10; 328(1):74-88.
    View in: PubMed
    Score: 0.135
  7. Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study. BMC Health Serv Res. 2022 May 09; 22(1):623.
    View in: PubMed
    Score: 0.114
  8. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):142-148.
    View in: PubMed
    Score: 0.097
  9. Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy. J Infect Dis. 2017 07 01; 216(1):82-91.
    View in: PubMed
    Score: 0.081
  10. Cardiovascular Disease, Statins, and HIV. J Infect Dis. 2016 Oct 01; 214 Suppl 2:S83-92.
    View in: PubMed
    Score: 0.077
  11. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine. 2016 Apr 07; 34(16):1945-55.
    View in: PubMed
    Score: 0.073
  12. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration. AIDS Res Hum Retroviruses. 2016 May; 32(5):456-62.
    View in: PubMed
    Score: 0.073
  13. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA. 2015 Mar 24-31; 313(12):1232-9.
    View in: PubMed
    Score: 0.069
  14. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. J Med Virol. 2015 Apr; 87(4):544-52.
    View in: PubMed
    Score: 0.069
  15. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Sci China Life Sci. 2010 Feb; 53(2):195-203.
    View in: PubMed
    Score: 0.049
  16. HIV-1 replication and pathogenesis in the human thymus. Curr HIV Res. 2003 Jul; 1(3):275-85.
    View in: PubMed
    Score: 0.031
  17. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. Biomed Res Int. 2017; 2017:2067479.
    View in: PubMed
    Score: 0.020
  18. The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env. J Virol. 2009 Nov; 83(22):11715-25.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.